CXCL10 and rheumatoid arthritis: RA-FLSs treated with IL-27 and TNFα further upregulated the expression of ICAM-1, VCAM-1, CXCL9, and CXCL10 (126), indicating that IL-27 combined with TNFα may contribute to inflammatory component production.